Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Ivy Chung
Introduction
Ivy Chung is a prominent inventor based in Boston, MA (US). She has made significant strides in the field of cancer research, particularly in addressing taxane-resistant cancers. Her work has the potential to impact the lives of many patients facing this challenging condition.
Latest Patents
Ivy Chung holds a patent for her innovative work titled "Diagnosis and treatment of taxane-resistant cancers." This patent outlines methods and assays related to diagnosing and treating cancers that are resistant to taxane therapies. The methods involve determining the expression levels of miR-135 in biological samples from subjects with or suspected of having taxane-resistant cancers. Additionally, her patent includes methods for treating such cancers by administering an inhibitor of the miR-135 pathway alongside a taxane to patients in need.
Career Highlights
Ivy Chung is affiliated with the Children's Medical Center Corporation, where she continues her research and development efforts. Her dedication to advancing cancer treatment showcases her commitment to improving patient outcomes through innovative solutions.
Collaborations
Ivy has collaborated with notable colleagues, including Bruce R Zetter and Amy Holleman. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Ivy Chung's contributions to cancer research, particularly in the realm of taxane-resistant cancers, highlight her innovative spirit and dedication to improving healthcare. Her patent and ongoing work at the Children's Medical Center Corporation exemplify the impact of her research on the medical community.